Enhancing exposure-based therapy from a translational research perspective

Behaviour Research and Therapy

Volumn 45, Issue 9, 2007, Pages 1987-2001

  Hofmann, Stefan G ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

Anxiety disorders; d cycloserine; Exposure therapy; Extinction learning; Glutamate; Glycine; NMDA; Phobias; Translational research

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CYCLOSERINE; GLUTAMIC ACID; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLACEBO;

ABSENCE OF SIDE EFFECTS; AGORAPHOBIA; ANXIETY DISORDER; ARTICLE; BEHAVIOR THERAPY; BEHAVIORISM; CLINICAL RESEARCH; COGNITION; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE RESPONSE; DRUG EFFICACY; DRUG EXPOSURE; DRUG HALF LIFE; DRUG MECHANISM; DRUG RESPONSE; EXPOSURE THERAPY; FEAR; HUMAN; LEARNING; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; OPTIMAL DRUG DOSE; PANIC; PHOBIA; PSYCHOEDUCATION; PSYCHOTHERAPY; REINFORCEMENT; RELAPSE; SINGLE DRUG DOSE;

ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; COMBINED MODALITY THERAPY; CYCLOSERINE; DESENSITIZATION, PSYCHOLOGIC; EXTINCTION, PSYCHOLOGICAL; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PANIC DISORDER; PHOBIC DISORDERS;

EID: 34547701926     PISSN: 00057967     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brat.2007.06.006     Document Type: Article

References (107)

1. Abramowitz J.S. The psychological treatment of obsessive-compulsive disorder. Canadian Journal of Psychiatry 51 (1996) 407-416
2. Barlow D.H., Gorman J.M., Shear M.K., and Woods S.W. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. Journal of the American Medical Association 283 (2000) 2529-2536
3. Biferno M.A., and Dawson M.E. The onset of contingency awareness and electrodermal classical conditioning: An analysis of temporal relationships during acquisition and extinction. Psychophysiology 14 (1977) 164-171
4. Blair H.T., Tinkelman A., Moita M.A., and LeDoux J.E. Associative plasticity in neurons of the lateral amygdala during auditory fear conditioning. Annals of the New York Academy of Science 985 (2003) 485-487
5. Bleisdell A.P., Sawa K., Leising K.J., and Waldmann M.R. Causal reasoning in rats. Science 311 (2006) 1020-2022
6. Bliss T.V., and Collingridge G.L. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
7. Boje K.M., Wong G., and Skolnick P. Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures. Brain Research 603 (1993) 207-214
8. Bouton M.E. Context, time, and memory retrieval in the interference paradigms of Pavlovian learning. Psychological Bulletin 114 (1993) 80-99
9. Bouton M.E. Context, ambiguity, and unlearning: Sources of relapse after behavioral extinction. Biological Psychiatry 52 (2002) 976-986
10. Bouton M.E. Context and behavioral processes in extinction. Learning and Memory 11 (2004) 485-494
11. Bouton M.E., and Bolles R.C. Role of conditioned contextual stimuli in reinstatement of extinguished fear. Journal of Experimental Psychology: Animal Behavior Processes 5 (1979) 368-378
12. Bouton M.E., and Swartzentruber D. Sources of relapse after extinction in Pavlovian and instrumental learning. Clinical Psychology Review 11 (1991) 123-140
13. Cahill L., Weinberger N.M., Roozendaal B., and McGaugh J.L. Is the amygdale a locus of "conditioned fear"? Some questions and caveats. Neuron 23 (1999) 227-228
14. Clum G.A., Clum G., and Surls R. A meta-analysis of treatments for panic disorder. Journal of Consulting and Clinical Psychology 61 (1993) 317-326
15. Collinridge G.L., Kehl S.J., and McLennan H. Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. Journal of Physiology 224 (1983) 22-46
16. Davidson J.R.T., Foa E.B., Huppert J.D., Keefe F.J., Franklin M.E., Compton J.S., et al. Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Archives of General Psychiatry 61 (2004) 1005-1013
17. Davis M., Ressler K., Rothaum B.O., and Richardson R. Effects of d-cycloserine on extinction: Translation from preclinical and clinical work. Biological Psychiatry 60 (2006) 369-375
18. Davis M., Walker D.L., and Myers K.M. Role of the amygdale in fear extinction measured with potentiated startle. Annals of the New York Academy of Science 985 (2003) 218-232
19. Dirikx T., Hermans D., Vansteenwegen D., Baeyens F., and Eelen P. Reinstatement of extinguished conditioned responses and negative stimulus valence as a pathway to return of fear in humans. Learning and Memory 11 (2004) 549-554
20. D'Souza D.C., Gil R., Cassello K., Morrissey K., et al. IV glycine and oral d-cycloserine effects on plasma and CSF amino acids in healthy humans. Biological Psychiatry 47 (2000) 450-462
21. Falls W.A., Miserendino M.D., and Davis M. Extinction of fear-potentiated startle: Blockade by infusion of an NMDA antagonist into the amygdala. Journal of Neuroscience 12 (1992) 854-863
22. Fanselow M.S., and LeDoux J.E. Why we think placsticity underlying Pavlovian fear conditioning occurs in the basolateral amygdale. Neuron 23 (1999) 229-232
23. Feske U., and Chambless D.L. Cognitive behavioral versus exposure only treatment for social phobia: A meta-analysis. Behavior Therapy 26 (1995) 695-720
24. Foa E.B., Franklin M.E., and Moser J. Context in the clinic: How well do cognitive-behavioral therapies and medications work in combination?. Biological Psychiatry 10 (2002) 987-997
25. Foa E.B., and Kozak M.J. Emotional processing of fear: Exposure to corrective information. Psychological Bulletin 99 (1986) 20-35
26. Foa E.B., Dancu C.V., Hembree E.A., Jaycox L.H., Meadows E.A., and Street G.P. A comparison of exposure therapy, stress inoculation training, and their combination for reducing post-traumatic stress disorder in female assault victim. Journal of Consulting and Clinical Psychology 67 (1999) 194-200
27. Foa E.B., Liebowitz M.R., Kozak M.J., Davies S., Campeas R., Franklin M.E., et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry 162 (2005) 151-161
28. Franklin M.E., Abramowitz J.S., Bux D.A., Zoellner L.A., and Feeny N.C. Cognitive-behavioral therapy with and without medication in the treatment of obsessive-compulsive disorder. Professional Psychology: Research and Practice 33 (2002) 162-168
29. Goff D.C., and Coyle J.T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. American Journal of Psychiatry 158 (2001) 1367-1377
30. Goff D.C., Tsai G., Levitt J., Amicao E., Mannoach D., Schoenfeld D.A., et al. A placebo-controlled trial of d-cycloserine added to conventional neuroleptics in patients with schizophrenia. Archives of General Psychiatry 56 (1999) 21-27
31. Goodman W., Price L., Rasmussen S., and Mazure C. The Yale-Brown Obsessive-Compulsive Scale I: Development, use and reliability. Archives of General Psychiatry 46 (1989) 1006-1011
32. Grings W.W. Cognitive factors in electrodermal conditioning. Psychological Bulletin 79 (1973) 200-210
33. Guastella A.J., Dadds M.R., Lovibond P.F., Mitchell P., and Richardson G.A. A randomized controlled trial of the effect of d-cycloserine on exposure therapy for spider fear. Journal of Psychiatric Research 41 (2007) 466-471
34. Guastella A.J., Lovibon P., Dadds M.R., and Mitchell P. A randomized controlled trial of the effect of d-cycloserine on extinction and fear-conditioning in humans. Behaviour Research and Therapy 45 (2007) 663-672
35. Guy W. ECDEU assessment manual for psychopharmacology: Publication ADM 76-338. (pp. 217-222) (1976), US Department of Health, Education and Welfare, Washington, DC
36. Hebb D.O. The organization of behavior (1949), Wiley, New York, NY
37. Hermans D., Dirikx T., Vansteenwegenin D., Baeyens F., Van den Bergh O., and Eelen P. Reinstatement of fear responses in human aversive conditioning. Behaviour Research and Therapy 43 (2005) 533-551
38. Hofmann S.G., Meuret A.E., Smits J.A.J., Simon N.M., Pollack M.H., Eisenmenger K., et al. Augmentation of exposure therapy for social anxiety disorder with d-cycloserine. Archives of General Psychiatry 63 (2006) 298-304
39. Hofmann S.G., Pollack M.H., and Otto M.O. Augmentation treatment of psychotherapy for anxiety disorders with d-cycloserine. CNS Drug Reviews 12 (2006) 208-217
40. Hofmann, S.G. (in press). Cognitive processes during fear acquisition and extinction in animals and humans: Implications for exposure therapy of anxiety disorders. Clinical Psychology Review.
41. Jahr C.E., and Stevens C.F. Calcium permeability of the N-methyl-d-aspartate receptor channel in hippocampal neurons in culture. Proceedings of the National Academy of Science USA 90 (1993) 11573-11577
42. Kushner, M., Kim, S. W., Donahue, C., Thuras, P., Adson, D., Kotlyar M., et al. (in press). d-Cycloserine augmented exposure therapy for obsessive compulsive disorder. Biological Psychiatry.
43. Laake K., and Oeksengaard A.R. d-Cycloserine for Alzheimer's disease. Cochrane Database Systematic Review 2 (2002) CD003153
44. Land C., and Riccio D.C. d-Cycloserine: Effects on long-term retention of a conditioned response and on memory for contextual attributes. Neurobiology of Learning and Memory 72 (1999) 158-168
45. Lao J., Wang Y., Yasuda R.P., Dunah A.W., and Wolfe B.B. The majority of N-methyl-d-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Molecular Pharmacology 51 (1997) 79-86
46. Laube B., Hirai H., Sturgess M., Betz H., and Kuhse J. Molecular determinants of agonist discrimination by NMDA receptor subunits: Analysis of the glutamate binding site on the NR2B subunit. Neuron 18 (1997) 493-503
47. Laube B., Kuhse H., and Betz H. Evidence for a tetrameric structure of recombinant NMDA receptors. Journal of Neuroscience 18 (1998) 2954-2961
48. Ledgerwood L., Richardson R., and Cranney J. d-Cycloserine facilitates extinction of conditioned fear as assessed by freezing in rats. Behavioral Neuroscience 117 (2003) 341-505
49. Ledgerwood L., Richardson R., and Cranney J. d-Cycloserine and the facilitation of conditioned fear: Consequences for reinstatement. Behavioral Neuroscience 118 (2004) 505-513
50. Lee H.J., Choi J.S., Brown T.H., and Kim J.J. Amygdalar NMDA receptors are critical for the expression of multiple conditioned fear responses. Journal of Neuroscience 21 (2000) 4116-4124
51. Lelong V., Dauphin F., and Boulouard M. RS 67333 and d-cycloserine accelerates learning acquisition in the rat. Neuropharmacology 41 (2001) 517-522
52. Liebowitz M.R. Social phobia. Modern Problems of Pharmacopsychiatry 22 (1987) 141-173
53. Lipp O.V., and Edwards M.S. Effect of instructed extinction on verbal and autonomic indices of Pavlovian learning with fear-relevant conditional stimuli. Journal of Psychophysiology 16 (2002) 176-186
54. Lisman J. A mechanism for the Hebb and the anti-Hebb processes underlying learning and memory. Proceedings of the National Academy of Science USA 86 (1989) 9574-9578
55. Liu L., Wong T.P., Pozzza M.F., et al. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic placsticity. Science 304 (2004) 1021-1024
56. Lovibond P.F., Davis N.R., and O'Flaherty A.S. Protection from extinction in human fear conditioning. Behaviour Research and Therapy 38 (2000) 967-983
57. Lynch G., Larson J., Kelso S., Barrionuevo G., and Schottler F. Intracellular injections in EGTA block induction of hippocampal long-term potentiation. Nature 305 (1983) 719-721
58. MacDermott A.B., Mayer M.L., Westbrook G.L., Smith S.J., and Baker J.L. NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones. Nature 321 (1986) 519-522
59. Mackintosh N.J. A theory of attention: Variations in the associability of stimuli with reinforcement. Psychological Review 82 (1975) 276-278
60. Malenka R.C., and Nicoll R.A. Long-term potentiation-A decade of progress?. Science 285 (1999) 1870-1874
61. Marks I.M., Swinson R.P., Basaglu M., Kuch K., Nasirvani H., O'Sullivan G., et al. Alprazolam and exposure alone and combined in panic disorder with agoraphobia: A controlled study in London and Toronto. British Journal of Psychiatry 162 (1993) 776-787
62. Milad M.R., and Quirk G.J. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420 (2002) 70-74
63. Myers K.M., and Davis M. Behavioral and neural analysis of extinction: A review. Neuron 36 (2002) 567-584
64. Myers K.M., and Davis M. Mechanisms of fear extinction. Molecular Psychiatry 12 (2007) 120-150
65. Myers K.M., Ressler K.J., and Davis M. Different mechanisms of fear extinction dependent on length of time since fear acquisition. Learning and Memory 13 (2006) 216-223
66. Nair K.G.S., Epstein I.G., Baron H., and Mulinos M.G. Absorption, distribution and excretion of cycloserine in man. Antibiotic Annals (1956) 136-140
67. 2+ stores regulate the polarity and input specificity of synaptic medication. Nature 408 (2000) 584-588
68. Nowak G., Trullas R., Layer R., Skolnick P., and Paul I.A. Adaptive changes in the N-methyl-d-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. Journal of Pharmacology and Experimental Therapeutics 265 (1993) 1380-1386
69. Nowak L., Bregestovski P., Ascher P., Herbert A., and Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurons. Nature 307 (1984) 462-465
70. Öst L.G., Svensson L., Hellstrom K., and Lindwall R. One-session treatment of specific phobias in youths: A randomized clinical trial. Journal of Consulting and Clinical Psychology 69 (2001) 814-824
71. Orr S.P., Metzger L.J., Lasko N.B., Macklin M.L., Peri T., and Pitman R.K. De novo conditioning in trauma-exposed individuals with and without posttraumatic stress disorder. Journal of Abnormal Psychology 109 (2000) 290-298
72. Otto M.W., Basden S., Leyro T.M., McHugh K., and Hofmann S.G. Clinical perspectives on the combination of d-cycloserine and CBT for the treatment of anxiety disorders. CNS Spectrums 12 (2007) 51-61
73. Otto M.W., Smits J.A.J., and Reese H.E. Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: Review and analysis. Clinical Psychology: Science and Practice 12 (2005) 72-86
74. Parnas S.A., Weber M., and Richardson R. Effects of multiple exposures to d-cycloserine in extinction of conditioned fear in rats. Neurobiology of Learning and Memory 83 (2005) 224-231
75. Paul I.A., Nowak G., Layer R., Popik P., and Skolnick P. Adaptation of the N-methyl-d-aspartate receptor complex following chronic antidepressant treatments. Journal of Pharmacology and Experimental Therapeutics 269 (1994) 95-102
76. Pavlov I.P. Conditioned reflexes (1927), Oxford University Press, London, UK
77. Phelps E.A., Delgado M.R., Nearing K.J., and LeDoux J.E. Extinction learning in humans: Role of the amygdala and vmPFC. Neuron 43 (2004) 897-905
78. Popik P., Wrobel M., and Nowak G. Chronic treatment with antidepressants affect glycine/NMDA receptor function: Behavioral evidence. Neuropharmacology 39 (2000) 2278-2287
79. Posey D.J., Kem D.L., Swiezy N.B., Sweeten T.L., Wiegand R.E., and McDougle C.J. A pilot study of d-cycloserine in subjects with autistic disorder. American Journal of Psychiatry 161 (2004) 2115-2117
80. Powers M.B., Smits J.A., and Telch M.J. Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: A placebo-controlled trial. Journal of Consulting and Clinical Psychology 72 (2004) 448-454
81. Pussinen R., and Sirvio J. Effects of d-cycloserine, a positive modulator of N-methyl-d-aspartate receptors, and ST 587, a putative alpha-1 adrenergic agonist, individually and in combination, on the non-delayed and delayed foraging behaviour of rats assessed in the radial arm maze. Journal of Psychopharmacology 13 (1999) 171-179
82. Quartermain D., Mower J., Rafferty M.F., Herting R.L., and Lanthorn T.H. Acute but not chronic activation of the NMDA-coupled glycine receptor with d-cycloserine facilitates learning and retention. European Journal of Pharmacology 157 (1994) 7-12
83. Quirk G.J., Repa C., and LeDoux I.E. Fear conditioning enhances different temporal components of tone-evoked spike trains in auditory cortex and lateral amygdala. Neuron 19 (1995) 613-624
84. Repa J.C., Muller J., Apergis J., Desrochers T.M., Zhou Y., and LeDoux J.E. Two different lateral amygdala cell populations contribute to the initiation and storage of memory. Nature Neuroscience 4 (2001) 724-731
85. Rescorla R.A., and Heth C.D. Reinstatement of fear to an extinguished conditioned stimulus. Journal of Experimental Psychology: Animal Behavior Processes 1 (1975) 88-96
86. Rescorla R.A., and Wagner A.R. A theory of Pavlovian conditioning: Variations in the effectiveness of reinforcement and nonreinforcement (1972), Appleton-Century-Crofts, New York, NY
87. Ressler K.J., Rothbaum B.O., Tannenbaum L., Anderson P., Graap K., Zimand E., et al. Cognitive enhancers as adjuncts to psychotherapy: Use of d-cycloserine in phobic individuals to facilitate extinction of fear. Archives of General Psychiatry 61 (2004) 1136-1144
88. Richardson R., Ledgerwood L., and Cranney J. Facilitation of fear extinction by d-cycloserine: Theoretical and clinical implications. Learning and Memory 11 (2004) 510-516
89. Robbins S.J. Mechanisms underlying spontaneous recovery in auto-shaping. Journal of Experimental Psychology: Animal Behavioral Processes 16 (1990) 235-249
90. Rodriguez B.I., and Craske M.G. The effects of distraction during exposure to phobic stimuli. Behaviour Research and Therapy 31 (1993) 549-558
91. Rodriguez B.I., Craske M.G., Mineka S., and Hladeck D. Context-specificity of relapse: Effects of therapist and environmental context on return of fear. Behaviour Research and Therapy 39 (1999) 845-862
92. Rowland L.M., Astur R.S., Jung R.E., Bustillo J.R., Lauriello J., and Yeo R.A. Selective cognitive impairments associated with NMDA receptor blockade in humans. Neuropsychopharmacology 30 (2005) 633-639
93. Santini E., Muller R.U., and Quirk G.J. Consolidation of extinction learning involves transfer from NMDA-independent to NMDA-dependent memory. Journal of Neuroscience 21 (2001) 9009-9017
94. Schwartz B.L., Hashtroudi S., Herting R.L., Schwartz P., and Deutsch S.I. d-Cycloserine enhances implicit memory in Alzheimer patients. Neurology 46 (1996) 420-424
95. Shear M.K., Brown T.A., Barlow D.H., Money R., Sholomskas D.E., Woods S.W., et al. Multicenter Collaborative Panic Disorder Severity Scale. American Journal of Psychiatry 154 (1997) 1571-1575
96. Shell A.M., Dawson M.E., and Marinkovic K. Effects of potentially phobic conditioned stimuli on retention, reconditioning, and extinction of the conditioned skin conductance response. Psychophysiology 28 (1991) 140-153
97. Tsai G., Falk W., Gunther J., and Coyle J. Improved cognition in Alzheimer's disease with short-term d-cycloserine treatment. American Journal of Psychiatry 156 (1999) 467-469
98. Tolin, D. F., Pearlson, G. D., Krystal, J. H., Davies, M., Brady, R. E., Simon, N. M., et al. (2006). A controlled trial of d-cycloserine with brief CBT for panic disorder. Paper presented at the 40th annual convention of the Association for Behavioral and Cognitive Therapies, Chicago, IL.
99. Turner S.M., Beidel D.C., Dancu C.V., and Stanley M.A. An empirically derived inventory to measure social fears and anxiety: The Social Phobia and Anxiety Inventory. Psychological Assessment 1 (1989) 35-40
100. Walker D.L., and Davis M. The role of amygdale glutamate receptors in fear learning, potentiated startle, and extinction. Pharmacology, Biochemistry, and Behavior 71 (2002) 379-392
101. Walker D.L., Ressler K.J., Lu K.-T., and Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of d-cycloserine assessed with fear-potentiated startle. Journal of Neuroscience 22 (2002) 2343-2351
102. Watson J.B. Behaviorism (1924), Norton, New York, NY
103. Watson J.B., and Rayner R. Conditioned emotional reactions. Journal of Experimental Psychology 3 (1920) 1-34
104. Wilhelm, S., Buhlmann, U., Tolin, D. F., Meunier, S. A., Pearlson, G. D., Reese, H. E., et al. (2006). A randomized, double-blind, placebo-controlled medication trial with d-cycloserine for individuals with OCS currently receiving behavior therapy: A work in progress. Paper presented at the 40th annual convention of the Association for Behavioral and Cognitive Therapies, Chicago, IL.
105. Wolosker H. d-Serine regulation of NMDA receptor activity. Science STKE (2006) pe41
106. Zhu M., Nix D.E., Adam R.D.M., and Peloquin C.A. Pharmacokinetics of cycloserine under fasting conditions and with high-fat meal, orange juice, and antacids. Pharmacotherapy 21 (2001) 891-897
107. Zushida K., Sakurai M., Wada K., and Sekiguchi M. Facilitation of extinction learning for contextual fear memory by PEPA: A potentiator of AMPA receptors. Journal of Neuroscience 271 (2007) 158-166